A detailed history of Bristlecone Advisors, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Bristlecone Advisors, LLC holds 6,239 shares of MRNA stock, worth $229,907. This represents 0.03% of its overall portfolio holdings.

Number of Shares
6,239
Previous 6,192 0.76%
Holding current value
$229,907
Previous $735,000 43.4%
% of portfolio
0.03%
Previous 0.06%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$63.64 - $125.14 $2,991 - $5,881
47 Added 0.76%
6,239 $416,000
Q2 2024

Jul 25, 2024

BUY
$101.21 - $166.61 $6,781 - $11,162
67 Added 1.09%
6,192 $735,000
Q1 2024

Apr 22, 2024

BUY
$85.37 - $115.44 $10,756 - $14,545
126 Added 2.1%
6,125 $652,000
Q4 2023

Jan 25, 2024

BUY
$69.51 - $104.43 $10,635 - $15,977
153 Added 2.62%
5,999 $596,000
Q3 2023

Oct 16, 2023

SELL
$96.41 - $126.61 $19,282 - $25,322
-200 Reduced 3.31%
5,846 $603,000
Q2 2023

Aug 03, 2023

BUY
$118.5 - $160.53 $7,347 - $9,952
62 Added 1.04%
6,046 $734,000
Q1 2023

May 11, 2023

BUY
$135.66 - $197.02 $34,457 - $50,043
254 Added 4.43%
5,984 $919,000
Q4 2022

Feb 14, 2023

BUY
$118.38 - $210.04 $21,190 - $37,597
179 Added 3.22%
5,730 $1.03 Million
Q3 2022

Oct 27, 2022

SELL
$118.07 - $194.18 $9,327 - $15,340
-79 Reduced 1.4%
5,551 $656,000
Q2 2022

Jul 25, 2022

BUY
$117.13 - $176.59 $324,918 - $489,860
2,774 Added 97.13%
5,630 $804,000
Q1 2022

Apr 22, 2022

SELL
$126.46 - $235.05 $314,379 - $584,334
-2,486 Reduced 46.54%
2,856 $492,000
Q4 2021

Jan 19, 2022

BUY
$225.82 - $368.51 $1.21 Million - $1.97 Million
5,342 New
5,342 $1.36 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Bristlecone Advisors, LLC Portfolio

Follow Bristlecone Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bristlecone Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bristlecone Advisors, LLC with notifications on news.